{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:17:50Z","timestamp":1776878270073,"version":"3.51.2"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.06.075","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T21:51:42Z","timestamp":1354225902000},"page":"F192-F200","source":"Crossref","is-referenced-by-count":65,"special_numbering":"S5","title":["Implementation of Human Papillomavirus Immunization in the Developing World"],"prefix":"10.1016","volume":"30","author":[{"given":"Mark A.","family":"Kane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Wittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.06.075_bib0005","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http:\/\/globocan.iarc.fr (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0010","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann Oncol"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.06.075_bib0290","doi-asserted-by":"crossref","first-page":"F183","DOI":"10.1016\/j.vaccine.2012.06.031","article-title":"Upgrading public health programs for HPV prevention and control is possible in low and middle income countries","volume":"30","author":"Steben","year":"2012","journal-title":"Vaccine"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.06.075_bib0295","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","article-title":"Human papillomavirus vaccine introduction \u2013 The first five years","volume":"30","author":"Markowitz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0025","unstructured":"World Health Organization (WHO). Immunization. Geneva: World Health organization; 2012. Available at: http:\/\/www.who.int\/topics\/immunization\/en\/ (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0030","doi-asserted-by":"crossref","first-page":"821B","DOI":"10.2471\/BLT.11.08986","article-title":"Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries","volume":"89","author":"Lamontagne","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0035","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.vaccine.2011.04.078","article-title":"Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru","volume":"29","author":"Penny","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0040","unstructured":"GAVI Alliance. Human papillomavirus support. Available at: http:\/\/www.gavialliance.org\/support\/nvs\/human-papillomavirus-vaccine-support\/ (last accessed February 2012)."},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2012.06.075_bib0045","doi-asserted-by":"crossref","first-page":"K87","DOI":"10.1016\/j.vaccine.2008.05.003","article-title":"Introduction of human papillomavirus vaccines into developing countries\u2014international strategies for financing and procurement","volume":"26","author":"Andrus","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0050","unstructured":"GAVI Alliance. GAVI Alliance Progress Report 2010. Available at: http:\/\/www.gavialliance.org\/results\/gavi-progress-reports\/ (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0055","unstructured":"GAVI Alliance. Investing in immunisation through the GAVI Alliance - The Evidence Base 2011. Available at: http:\/\/www.gavialliance.org\/library\/publications\/the-evidence-base\/ (last accessed February 2012)."},{"issue":"2 Suppl","key":"10.1016\/j.vaccine.2012.06.075_bib0060","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ygyno.2010.01.029","article-title":"Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine","volume":"117","author":"Kane","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0065","unstructured":"PATH. Implementing HPV Vaccination Programs: Practical Experience from PATH. Seattle: PATH; 2011. Available at: www.rho.org\/files\/PATH_HPV-implementing-HPV-vaccination_2011.pdf (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0070","unstructured":"GAVI Alliance. Types of support 2011. Apply for support. Available at: http:\/\/www.gavialliance.org\/support\/apply\/ (last accessed February 2012)."},{"issue":"suppl 3","key":"10.1016\/j.vaccine.2012.06.075_bib0075","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0085","unstructured":"World Health Organization and Institut Catal\u00e0 d\u2019Oncologia (ICO). WHO\/ICO Information Centre on HPV and Cervical Cancer. Available at: http:\/\/www.who.int\/hpvcentre\/en\/.(last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0090","unstructured":"GAVI Alliance. GAVI Alliance Press releases. 17 November 2011. Available at: http:\/\/www.gavialliance.org\/library\/news\/press-releases\/2011\/gavi-takes-first-steps-to-introduce-vaccines-against-cervical-cancer-and-rubella\/ (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0095","unstructured":"WHO European Office for Europe: Preparing for the introduction of HPV vaccines in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2008. Available at: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0007\/98746\/E91432.pdf.(last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0100","unstructured":"World Health Organization (WHO). Human papillomavirus vaccines WHO position paper. Geneva: World Health Organization; 2009. Available at: http:\/\/www.who.int\/wer\/2009\/wer8415.pdf (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0105","unstructured":"WHO, PATH, UNFPA. Cervical cancer, human papillomavirus (HPV), and HPV vaccines: Key points for policy-makers and health professionals. Geneva: World Health organization; 2007. Available at: http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_RHR_08.14_eng.pdf.(last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0110","unstructured":"GAVI Alliance. Research and technical health institutes. Available at: http:\/\/www.gavialliance.org\/about\/partners\/research-and-technical-health-institutes (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0115","unstructured":"UNICEF\/WHO. Global immunization vision and strategy (GIVS): strategic framework for 2006-2015. Geneva: UNICEF\/WHO; 2005. Available at: http:\/\/whqlibdoc.who.int\/hq\/2005\/WHO_IVB_05.05.pdf.(last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0120","unstructured":"GAVI welcomes lower prices for life-saving vaccines. Available at: http:\/\/www.gavialliance.org\/library\/news\/press-releases\/2011\/gavi-welcomes-lower-prices-for-life-saving-vaccines\/ (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jnci\/djr053","article-title":"For cancers caused by HPV, two vaccines were just the beginning","volume":"103","author":"Peres","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0130","unstructured":"Pan American Health Organization (PAHO). PAHO Revolving Fund. Washington: Pan American Health Organization; 2011. Available at: http:\/\/new.paho.org\/hq\/index.php?option=com_content&task=view&id=1864&Itemid=2234&lang=en (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0135","unstructured":"United Nations Children's Fund (UNICEF). Progress for Children 2007-Primary Education. New York: United Nations Children's Fund; 2007. Available at: http:\/\/www.unicef.org\/progressforchildren\/2007n6\/files\/Progress_for_Children_-_No._6.pdf (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1753-6405.2009.00409.x","article-title":"Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia","volume":"33","author":"Watson","year":"2009","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0145","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.39541.534109.BE","article-title":"Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study","volume":"336","author":"Brabin","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0150","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jadohealth.2007.02.015","article-title":"Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant","volume":"40","author":"Pedersen","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0160","first-page":"159","article-title":"An assessment of the readiness for the introduction of the HPV vaccine in Uganda","volume":"12","author":"Katahoire","year":"2008","journal-title":"Afr J Reprod Health"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0165","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1590\/S0036-36342010000300007","article-title":"Formative research to shape HPV vaccine introduction strategies in Peru","volume":"52","author":"Bartolini","year":"2010","journal-title":"Salud Publica de Mexico"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1875035401003010096","article-title":"Assessing introduction of HPV vaccine in India: phase 1 formative study","volume":"3","author":"Jacob","year":"2010","journal-title":"The Open Vaccine Journal"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1071\/SH09123","article-title":"HPV vaccine introduction in Vietnam: formative research findings","volume":"7","author":"Nguyen","year":"2010","journal-title":"Sexual Health"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0180","unstructured":"Parker S. The perverse politics of Gardasil. Center for Urban Renewal and Education. Available at: http:\/\/www.urbancure.org\/article.asp?id=3026&tag= (last accessed October 2011)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/sti.2010.048017","article-title":"Human papillomavirus vaccine and behavioural disinhibition","volume":"87","author":"Schuler","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2012.06.075_bib0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archpediatrics.2009.50","article-title":"Socio-cultural issues in the introduction of human papillomavirus vaccines in low-resource settings","volume":"163","author":"Bingham","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0195","unstructured":"Remes P, Selestine V, Changalucha J, Ross D, Wight D, de Sanjose S, et al. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils and religious leaders in northwest Tanzania. Vaccine (Unpublished data, in press)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0200","unstructured":"PATH. RHO Cervical Cancer Library. Available at: http:\/\/www.rho.org\/cervical-cancer-library.htm (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0205","unstructured":"Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, et al. HPV vaccination in Tanzanian schoolgirls: cluster-randomised trial comparing two vaccine delivery strategies. J Infect Dis (Unpublished data, in press)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0210","first-page":"373","article-title":"Annual high-quality wellness visits for adolescents: a standard whose time has come","volume":"71","author":"Sexton","year":"2010","journal-title":"N C Med J"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0215","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archpedi.1997.02170460096021","article-title":"The American Medical Association Guidelines for Adolescent Preventive Services","volume":"151","author":"Elster","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0220","unstructured":"Jumaan A, Ghanem S, Taher J, Braikat M, Al Awaidy S, Dbaibo GS. Prospects and challenges in the introduction of HPV vaccines in the extended middle east and north africa region. Vaccine, in press."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0225","unstructured":"World Health Organization (WHO). Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009. Geneva: World Health Organization; 2009. Available at: http:\/\/www.who.int\/wer\/2009\/wer8432.pdf (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0230","unstructured":"Centers for Disease Control and Prevention (CDC). Reports of health concerns following HPV vaccination. Atlanta: Centers for Disease Control and Prevention; 2011. Available at: http:\/\/www.cdc.gov\/vaccinesafety\/vaccines\/hpv\/gardasil.html (last accessed February 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0235","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0240","doi-asserted-by":"crossref","unstructured":"Intlekofer KA, Cunningham MJ, Caplan AL. The HPV vaccine controversy. Virtual Mentor 2012;14:39-49. Available at: http:\/\/virtualmentor.ama-assn.org\/2012\/01\/msoc1-1201.html (last accessed January 2012).","DOI":"10.1001\/virtualmentor.2012.14.1.msoc1-1201"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0245","unstructured":"The Economist. Polio eradication. Available at: http:\/\/www.economist.com\/blogs\/lexington\/2010\/04\/eradicating_polio (last accessed January 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0250","doi-asserted-by":"crossref","unstructured":"Global Advisory Committee on Vaccine Safety (GACVS), WHO secretariat. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Review of Vaccines, 2009, 8:705-716.","DOI":"10.1586\/erv.09.40"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0255","unstructured":"Cervical Cancer Action, UICC, PATH. Evidence of support for improved cervical cancer prevention in developing countries. Geneva: Union for International Cancer Control; 2011. Available at: http:\/\/www.uicc.org\/resources\/evidence-support-improved-cervical-cancer-prevention-developing-countries (last accessed June 2012)."},{"key":"10.1016\/j.vaccine.2012.06.075_bib0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1875035400902010113","article-title":"Policy development for human papillomavirus vaccine introduction in low-resource settings","volume":"2","author":"Tsui","year":"2009","journal-title":"The Open Vaccine Journal"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0968-8080(08)32409-4","article-title":"Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications","volume":"16","author":"Goldie","year":"2008","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1741-7015-9-54","article-title":"Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models","volume":"9","author":"Jit","year":"2011","journal-title":"BMC Med"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.06.075_bib0300","doi-asserted-by":"crossref","first-page":"F157","DOI":"10.1016\/j.vaccine.2012.06.091","article-title":"Modeling preventative strategies against human papillomavirus-related disease in developed countries","volume":"30","author":"Canfell","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0280","doi-asserted-by":"crossref","first-page":"675858","DOI":"10.1155\/2011\/675858","article-title":"Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries","volume":"2011","author":"Natunen","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.06.075_bib0285","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.318.7186.769","article-title":"Surveillance of congenital rubella in Great Britain, 1971-96","volume":"318","author":"Tookey","year":"1999","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:51:57Z","timestamp":1562385117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":57,"alternative-id":["S0264410X12009565"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}